CombinatoRx ( is tapping Tripos Discovery Research (TDR; technology through a service agreement. CombinatoRx has identified synergistic activity of compounds with its combination high-throughput screening technology, cHTS™. Under the service contract, TDR will optimize these candidates and partner ADME services.

This site uses Akismet to reduce spam. Learn how your comment data is processed.